Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents--rationale and protocol

Authors :: Wicklow, Brandy
Wittmeier, Kristy
t'Jong, Geert W.
McGavock, Jonathon
Robert, Marni
Duhamel, Todd
Dolinsky, Vernon W.
Source :: Biochemistry and Cell Biology. October 1, 2015, p522, 9 p.
Publication Year :: 2015
Abstract: Abstract: Non-alcoholic fatty liver (NAFL) disease (NAFLD) affects 30% of overweight adolescents and increases the risk of type 2 diabetes mellitus (T2D). Resveratrol is a naturally occurring compound with potential [...]

Subjects :: Insulin resistance -- Prevention
Diabetes in children -- Physiological aspects
Liver diseases -- Care and treatment
Resveratrol -- Health aspects
Type 2 diabetes -- Physiological aspects
Biological sciences

Tools